Clinical trials
Completed Observational Adrenal Hyperplasia, Congenital trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Hospices Civils de Lyon | 2 |
| Adrenas Therapeutics Inc | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Hacettepe University | 1 |
| Haukeland University Hospital | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Lehigh University | 1 |
| Luminex Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adrenal Hyperplasia, Congenital | 19 |
| Congenital Hypothyroidism | 2 |
| Cystic Fibrosis | 2 |
| Disorders of Sex Development | 2 |
| Ovotesticular Disorders of Sex Development | 2 |
| Acromegaly | 1 |
| Adrenal Gland Neoplasms | 1 |
| Adrenal Insufficiency | 1 |
| Adrenocortical Adenoma | 1 |
| Adrenoleukodystrophy | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.